journal article Open Access Aug 01, 2022

Impact of Clinical Pharmacist-Led Interventions on Drug-Related Problems Among Pediatric Cardiology Patients: First Palestinian Experience

View at Publisher Save 10.2147/iprp.s374256
Topics

No keywords indexed for this article. Browse by subject →

References
37
[1]
Ahmad JAMA (2021) 10.1001/jama.2021.5469
[2]
Watt J Cardiovasc Pharmacol (2011) 10.1097/fjc.0b013e318213aac2
[3]
Gelchu SAGE Open Med (2019) 10.1177/2050312119860401
[4]
Tigabu J Res Pharm Pract (2014) 10.4103/2279-042x.132702
[5]
PCNE. Classification for drug-related problems V9.1; 2020. Available from: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Accessed July 27, 2022.
[6]
Ahmed JPRI (2021) 10.9734/jpri/2021/v33i59a34321
[7]
Rashed Br J Clin Pharmacol (2014) 10.1111/bcp.12270
[8]
Saldanha BMJ open (2020) 10.1136/bmjopen-2019-035848
[9]
Leopoldino BMC Pediatr (2019) 10.1186/s12887-019-1499-2
[10]
AlAzmi Drug Healthc Patient Saf (2019) 10.2147/dhps.s220081
[11]
Nascimento Rev Paul Pediatr (2020) 10.1590/1984-0462/2020/38/2018134
[12]
[13]
Viktil Basic Clin Pharmacol Toxicol (2008) 10.1111/j.1742-7843.2007.00206.x
[14]
Eichenberger Pharm World Sci (2010) 10.1007/s11096-010-9377-x
[15]
Sabry Minerva Pediatr (2016)
[16]
Nguyen TH, Le VTT, Quach DN, et al. Drug-related problems in prescribing for pediatric outpatients in Vietnam. Healthcare. 2021;9(3):227. doi:10.3390/healthcare9020227 10.3390/healthcare9030327
[17]
Naseef H, Amria A, Asrawi A, et al. The acceptance and awareness of healthcare providers towards doctor of pharmacy (Phram D) in the Palestinian health care system. Saudi Pharmaceut J. 2020;28(9):1068–1074. doi:10.1016/j.jsps.2020.07.007 10.1016/j.jsps.2020.07.007
[18]
(2019)
[19]
Xiao-Xiao Front Pharmacol (2020) 10.3389/fphar.2020.571906
[20]
Penm Health Policy Plan (2014) 10.1093/heapol/czt067
[21]
Tasaka J Pharamaceut Health Care Sci (2018) 10.1186/s40780-018-0125-z
[22]
Francis Saudi Pharmaceut J (2014) 10.1016/j.jsps.2014.02.011
[23]
Ramos Front Pharmacol (2021) 10.3389/fphar.2021.579489
[24]
Stephenson Br J Clin Pharmacol (2005) 10.1111/j.1365-2125.2005.02445.x
[25]
Kim J Clin Pharmacol (2021) 10.1002/jcph.1864
[26]
Daniel J Clin Case Rep Trials (2018) 10.46619/joccr.2018.1-1001
[27]
Jani J Pediatr (2008) 10.1016/j.jpeds.2007.09.046
[28]
Pontefract BMJ Qual Saf (2018) 10.1136/bmjqs-2017-007135
[29]
Carroll JAMA (2017) 10.1001/jama.2017.16193
[30]
Lyu PLoS One (2017) 10.1371/journal.pone.0181970
[31]
Dalton Integr Pharm Res Pract (2017) 10.2147/iprp.s108047
[32]
Bizri BMC Public Health (2021) 10.1186/s12889-021-11580-4
[33]
Emre Turk J Pharmaceut Sci (2021) 10.4274/tjps.galenos.2020.66735
[34]
Khan Int J Pharm Clin Res (2014)
[35]
Alagiriswami Indian J Pharm Pract (2009)
[36]
Law Arch Dis Child (2010) 10.1136/adc.2010.190322.10
[37]
PCNE-Classification v9.1. Published Online 2020. Available from: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Accessed July 27, 2022.
Metrics
6
Citations
37
References
Details
Published
Aug 01, 2022
Vol/Issue
Volume 11
Pages
127-137
License
View
Cite This Article
Mohammed Kamel Elhabil, Mirghani Abdelrahman Yousif, Kannan O Ahmed, et al. (2022). Impact of Clinical Pharmacist-Led Interventions on Drug-Related Problems Among Pediatric Cardiology Patients: First Palestinian Experience. Integrated Pharmacy Research and Practice, Volume 11, 127-137. https://doi.org/10.2147/iprp.s374256